Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heterocyclic Compounds, 3-Ring | 2 | 2020 | 215 | 0.800 |
Why?
|
| Botswana | 7 | 2023 | 1040 | 0.610 |
Why?
|
| Appointments and Schedules | 1 | 2021 | 417 | 0.590 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2020 | 615 | 0.580 |
Why?
|
| Hepatitis C, Chronic | 1 | 2024 | 1031 | 0.530 |
Why?
|
| Genital Neoplasms, Female | 1 | 2021 | 523 | 0.530 |
Why?
|
| Hepatitis C | 1 | 2024 | 1591 | 0.460 |
Why?
|
| Anti-Retroviral Agents | 2 | 2020 | 1715 | 0.460 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.440 |
Why?
|
| Musculoskeletal Diseases | 1 | 2019 | 581 | 0.440 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1071 | 0.440 |
Why?
|
| Orthopedics | 1 | 2019 | 904 | 0.350 |
Why?
|
| Medical Oncology | 1 | 2021 | 2265 | 0.340 |
Why?
|
| Cost of Illness | 1 | 2019 | 1859 | 0.340 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 2400 | 0.280 |
Why?
|
| Health Care Costs | 1 | 2019 | 3209 | 0.260 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2023 | 2020 | 0.250 |
Why?
|
| Oxazines | 2 | 2020 | 298 | 0.200 |
Why?
|
| HIV Infections | 3 | 2020 | 16718 | 0.170 |
Why?
|
| Alkynes | 1 | 2020 | 306 | 0.170 |
Why?
|
| Cyclopropanes | 1 | 2020 | 416 | 0.170 |
Why?
|
| Benzoxazines | 1 | 2020 | 301 | 0.160 |
Why?
|
| Prescriptions | 1 | 2021 | 387 | 0.160 |
Why?
|
| Pyridones | 2 | 2020 | 712 | 0.160 |
Why?
|
| Hip Injuries | 1 | 2019 | 80 | 0.160 |
Why?
|
| Neck Injuries | 1 | 2019 | 152 | 0.150 |
Why?
|
| Arm Injuries | 1 | 2019 | 160 | 0.150 |
Why?
|
| Tanzania | 2 | 2019 | 1346 | 0.150 |
Why?
|
| Radiation Oncology | 1 | 2023 | 555 | 0.150 |
Why?
|
| Lactulose | 1 | 2017 | 33 | 0.150 |
Why?
|
| Leg Injuries | 1 | 2019 | 178 | 0.150 |
Why?
|
| Neural Tube Defects | 1 | 2019 | 256 | 0.150 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2019 | 264 | 0.140 |
Why?
|
| Hepacivirus | 1 | 2024 | 1379 | 0.140 |
Why?
|
| Multiple Trauma | 1 | 2019 | 367 | 0.140 |
Why?
|
| Spinal Injuries | 1 | 2019 | 301 | 0.130 |
Why?
|
| Patents as Topic | 1 | 2016 | 103 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2020 | 1959 | 0.130 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2020 | 2559 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2019 | 707 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 20822 | 0.120 |
Why?
|
| Leishmania donovani | 1 | 2014 | 65 | 0.110 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2014 | 94 | 0.110 |
Why?
|
| Piperazines | 2 | 2020 | 2488 | 0.110 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 188 | 0.110 |
Why?
|
| Employment | 1 | 2019 | 1132 | 0.100 |
Why?
|
| Osteoporotic Fractures | 1 | 2017 | 401 | 0.100 |
Why?
|
| Gastrointestinal Agents | 1 | 2017 | 494 | 0.100 |
Why?
|
| Social Class | 1 | 2021 | 1999 | 0.100 |
Why?
|
| Antiviral Agents | 1 | 2024 | 2987 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 1 | 2014 | 563 | 0.100 |
Why?
|
| Medicaid | 1 | 2024 | 2736 | 0.090 |
Why?
|
| Clostridium Infections | 1 | 2017 | 548 | 0.090 |
Why?
|
| Income | 1 | 2019 | 1913 | 0.090 |
Why?
|
| Mothers | 1 | 2020 | 2165 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 2418 | 0.090 |
Why?
|
| Premature Birth | 1 | 2021 | 1721 | 0.090 |
Why?
|
| Disabled Persons | 1 | 2019 | 1212 | 0.080 |
Why?
|
| Accidental Falls | 1 | 2017 | 1062 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2017 | 955 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2019 | 1288 | 0.080 |
Why?
|
| Protozoan Proteins | 1 | 2014 | 827 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2019 | 2708 | 0.080 |
Why?
|
| Anti-HIV Agents | 2 | 2020 | 4256 | 0.080 |
Why?
|
| Female | 13 | 2023 | 380194 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 2026 | 0.080 |
Why?
|
| Biological Products | 1 | 2016 | 860 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1863 | 0.070 |
Why?
|
| Humans | 18 | 2024 | 744343 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2014 | 2751 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3158 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2021 | 25625 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 1376 | 0.060 |
Why?
|
| Pregnancy | 3 | 2021 | 29144 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1903 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8388 | 0.060 |
Why?
|
| Intestines | 1 | 2013 | 1924 | 0.060 |
Why?
|
| Young Adult | 2 | 2020 | 56430 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2942 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 25043 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 40561 | 0.050 |
Why?
|
| Antibodies, Viral | 2 | 2023 | 3176 | 0.050 |
Why?
|
| Infant | 2 | 2021 | 35136 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11524 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39050 | 0.040 |
Why?
|
| Adult | 4 | 2020 | 214055 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77449 | 0.040 |
Why?
|
| United States | 2 | 2024 | 69872 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2020 | 53288 | 0.040 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2019 | 142 | 0.040 |
Why?
|
| Hospitalization | 1 | 2017 | 10262 | 0.040 |
Why?
|
| Prebiotics | 1 | 2017 | 44 | 0.040 |
Why?
|
| Middle Aged | 6 | 2023 | 213383 | 0.040 |
Why?
|
| Benchmarking | 1 | 2023 | 1042 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2019 | 41006 | 0.030 |
Why?
|
| Rwanda | 1 | 2018 | 703 | 0.030 |
Why?
|
| Supreme Court Decisions | 1 | 2016 | 128 | 0.030 |
Why?
|
| Aged | 4 | 2023 | 163280 | 0.030 |
Why?
|
| Child | 2 | 2021 | 77709 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 15226 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 6773 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 72290 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 2297 | 0.030 |
Why?
|
| Fetus | 1 | 2019 | 1880 | 0.030 |
Why?
|
| Biopsy | 1 | 2023 | 6756 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 2795 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 4560 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 85781 | 0.020 |
Why?
|
| Integrases | 1 | 2013 | 533 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 783 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1799 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2014 | 2256 | 0.020 |
Why?
|
| Male | 4 | 2023 | 350118 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3278 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6489 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2019 | 2616 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 713 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 1701 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3022 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 3689 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 3144 | 0.020 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2013 | 934 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12354 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5179 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7785 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 6314 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6386 | 0.020 |
Why?
|
| Monocytes | 1 | 2014 | 2596 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2017 | 3528 | 0.010 |
Why?
|
| Hospitals | 1 | 2017 | 3952 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2013 | 4161 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4851 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 3036 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13815 | 0.010 |
Why?
|
| Cell Movement | 1 | 2013 | 5217 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5720 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21746 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 19229 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10481 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 9727 | 0.010 |
Why?
|
| Mice | 2 | 2014 | 81183 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11483 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 16365 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 57776 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 168757 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23403 | 0.010 |
Why?
|
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_